This document provides information on various types of colonic polyps. It discusses neoplastic polyps such as adenomas, which can be classified as exophytic or non-exophytic. Non-exophytic adenomas, previously called flat adenomas, occur more frequently with high-grade dysplasia. The document also covers non-neoplastic polyps such as hyperplastic polyps and hamartomas. Different classification systems are described including endoscopic, histopathological, and clinicopathological classifications. Specific polyposis syndromes associated with multiple polyp growth are mentioned.
This document discusses colorectal polyps and carcinomas, including definitions, classifications, diagnoses, and characterizations. It describes the pathological classifications of neoplastic and non-neoplastic polyps. Neoplastic polyps include adenomas, carcinomas, and submucosal tumors. Adenomas can be characterized by their histopathology, endoscopic appearance, and associations with polyposis syndromes. Serrated adenomas and familial adenomatous polyposis are also summarized. The document outlines hereditary non-polypoid colorectal cancer and submucosal tumors of the colon.
This document summarizes colonic neoplastic polyps. It defines polyps and classifies them based on their appearance, size, and whether they have stalks. Adenomas are the most common type of polyp and can be tubular, tubulovillous, or villous based on histology. Dysplasia is also classified from mild to severe. Risk of malignancy increases with polyp size over 1cm, villous histology, higher dysplasia grade, or presence of advanced pathology. Dietary and lifestyle factors can influence polyp risk. Initial treatment is full colonoscopy and polyp removal. Follow-up depends on features of the polyp.
The document discusses tumors of the small and large intestines. It classifies intestinal tumors and provides details on various benign and malignant tumor types. The most common tumors are epithelial tumors, with colorectal cancer representing 70% of all gastrointestinal malignancies. Adenomas are precursors to most colorectal cancers. Risk factors include inflammatory bowel disease, familial polyposis, and diet. Prognosis and treatment depend on tumor stage and characteristics.
This document discusses different types of colorectal polyps. It defines a polyp as any lesion elevated above the bowel surface and classifies polyps as neoplastic (adenomatous or polyposis syndromes like FAP) or non-neoplastic (hamartomas, metaplasias, pseudopolyps). It describes adenomatous polyps in detail and the adenoma-carcinoma sequence. It also discusses juvenile polyps, Peutz-Jeghers syndrome, inflammatory polyps, connective tissue polyps, and hereditary colorectal cancer syndromes like FAP and HNPCC. Management options including endoscopic, transanal, abdominal procedures and surgery are provided.
This document provides an overview of intestinal polyps. It begins with an introduction and relevant anatomy. Polyps are then classified based on size, attachment, and cellular architecture. Both non-neoplastic and neoplastic polyps are discussed. Non-neoplastic polyps include hyperplastic, juvenile, Peutz-Jeghers, inflammatory, Cronkhite-Canada, and Cowden polyps. Neoplastic polyps include adenomatous and syndromic polyps associated with Familial Adenomatous Polyposis (FAP) and Hereditary Nonpolyposis Colon Cancer (HNPCC). The pathogenesis and molecular biology of adenomatous polyps is also reviewed. Management strategies
This document discusses various causes and radiological findings of large bowel obstruction. The most common causes are cancer (60%), diverticulitis (20%), and volvulus (5%). Radiological findings of large bowel obstruction include a peripherally located distended bowel with haustral markings and no air distal to the site of obstruction. Barium enema can demonstrate the level and degree of obstruction, and may show findings like an "inverted U-shaped" sigmoid loop or "bird's beak" sign in sigmoid volvulus. CT scan with oral and IV contrast is also useful to evaluate bowel obstruction and its underlying cause.
Sites of the highest risk are the duodenum, for adenocarcinomas, and the ileum, for carcinoids and lymphomas.
In industrialized countries, small bowel cancers are predominantly adenocarcinomas;
In developing countries, lymphomas are much more common.
The incidence of small bowel cancer rises with age and has generally been higher among males than among females.
The risk factors for small bowel cancer include
Dietary factor
Cigarette smoking,
Alcohol intake,
Medical conditions -Crohn's disease, familial adenomatous polyposis, cholecystectomy, peptic ulcer disease, and cystic fibrosis.
The protective factors may include rapid cell turnover, a general absence of bacteria, an alkaline environment, and low levels of activating enzymes of precarcinogens.
This document discusses colorectal polyps and carcinomas, including definitions, classifications, diagnoses, and characterizations. It describes the pathological classifications of neoplastic and non-neoplastic polyps. Neoplastic polyps include adenomas, carcinomas, and submucosal tumors. Adenomas can be characterized by their histopathology, endoscopic appearance, and associations with polyposis syndromes. Serrated adenomas and familial adenomatous polyposis are also summarized. The document outlines hereditary non-polypoid colorectal cancer and submucosal tumors of the colon.
This document summarizes colonic neoplastic polyps. It defines polyps and classifies them based on their appearance, size, and whether they have stalks. Adenomas are the most common type of polyp and can be tubular, tubulovillous, or villous based on histology. Dysplasia is also classified from mild to severe. Risk of malignancy increases with polyp size over 1cm, villous histology, higher dysplasia grade, or presence of advanced pathology. Dietary and lifestyle factors can influence polyp risk. Initial treatment is full colonoscopy and polyp removal. Follow-up depends on features of the polyp.
The document discusses tumors of the small and large intestines. It classifies intestinal tumors and provides details on various benign and malignant tumor types. The most common tumors are epithelial tumors, with colorectal cancer representing 70% of all gastrointestinal malignancies. Adenomas are precursors to most colorectal cancers. Risk factors include inflammatory bowel disease, familial polyposis, and diet. Prognosis and treatment depend on tumor stage and characteristics.
This document discusses different types of colorectal polyps. It defines a polyp as any lesion elevated above the bowel surface and classifies polyps as neoplastic (adenomatous or polyposis syndromes like FAP) or non-neoplastic (hamartomas, metaplasias, pseudopolyps). It describes adenomatous polyps in detail and the adenoma-carcinoma sequence. It also discusses juvenile polyps, Peutz-Jeghers syndrome, inflammatory polyps, connective tissue polyps, and hereditary colorectal cancer syndromes like FAP and HNPCC. Management options including endoscopic, transanal, abdominal procedures and surgery are provided.
This document provides an overview of intestinal polyps. It begins with an introduction and relevant anatomy. Polyps are then classified based on size, attachment, and cellular architecture. Both non-neoplastic and neoplastic polyps are discussed. Non-neoplastic polyps include hyperplastic, juvenile, Peutz-Jeghers, inflammatory, Cronkhite-Canada, and Cowden polyps. Neoplastic polyps include adenomatous and syndromic polyps associated with Familial Adenomatous Polyposis (FAP) and Hereditary Nonpolyposis Colon Cancer (HNPCC). The pathogenesis and molecular biology of adenomatous polyps is also reviewed. Management strategies
This document discusses various causes and radiological findings of large bowel obstruction. The most common causes are cancer (60%), diverticulitis (20%), and volvulus (5%). Radiological findings of large bowel obstruction include a peripherally located distended bowel with haustral markings and no air distal to the site of obstruction. Barium enema can demonstrate the level and degree of obstruction, and may show findings like an "inverted U-shaped" sigmoid loop or "bird's beak" sign in sigmoid volvulus. CT scan with oral and IV contrast is also useful to evaluate bowel obstruction and its underlying cause.
Sites of the highest risk are the duodenum, for adenocarcinomas, and the ileum, for carcinoids and lymphomas.
In industrialized countries, small bowel cancers are predominantly adenocarcinomas;
In developing countries, lymphomas are much more common.
The incidence of small bowel cancer rises with age and has generally been higher among males than among females.
The risk factors for small bowel cancer include
Dietary factor
Cigarette smoking,
Alcohol intake,
Medical conditions -Crohn's disease, familial adenomatous polyposis, cholecystectomy, peptic ulcer disease, and cystic fibrosis.
The protective factors may include rapid cell turnover, a general absence of bacteria, an alkaline environment, and low levels of activating enzymes of precarcinogens.
This document discusses various anomalies of the biliary tree that can occur during embryonic development, including choledochal cysts, anomalous pancreatobiliary junction, annular pancreas, and biliary atresia. It describes the embryology of the biliary system and pancreas. Common anomalies are discussed such as their presentation, diagnosis using imaging modalities, classification systems, and management approaches including various surgical procedures.
This document discusses various types of colorectal polyps and polyposis syndromes. It begins by defining different types of colorectal polyps based on size, attachment, cellular architecture, and histological appearance. Larger polyps have a higher likelihood of harboring cancer. The main polyposis syndromes discussed are familial adenomatous polyposis (FAP), hereditary non-polyposis colorectal cancer (HNPCC), Peutz-Jeghers syndrome, and juvenile polyposis syndrome. FAP is characterized by hundreds of colonic polyps and a 100% risk of colon cancer. Management involves prophylactic colectomy and surveillance of other organs for extracol
Barrett's esophagus; guidelines & new endoscopic techniquesMoon Splitting
The man has had heartburn for over 20 years and is concerned about his risk of Barrett's esophagus and esophageal cancer after reading an article. The article recommends those with chronic heartburn undergo endoscopy to evaluate for Barrett's esophagus. The document discusses Barrett's esophagus, its risks factors including longstanding GERD, obesity and male gender. Surveillance endoscopy is suggested for patients with Barrett's esophagus to screen for dysplasia or cancer.
Colonic polyposis refers to numerous polyps throughout the GI tract that are often precancerous. The most common type is familial adenomatous polyposis (FAP), an autosomal dominant condition caused by a mutation in the APC gene. People with FAP develop hundreds to thousands of colon polyps by their mid-30s, and colon cancer is inevitable without surgery to remove the colon. They are also at risk of polyps in the stomach and duodenum that can become cancerous. Treatment involves prophylactic colectomy, surveillance of the upper GI tract, and managing extracolonic manifestations such as osteomas and desmoid tumors.
This document discusses primary lymphomas of the gastrointestinal tract. It begins by providing background on lymphomas and noting that the gastrointestinal tract is a common extra-nodal site. The most common subtypes of primary GI lymphomas are then described, including their typical locations and risk factors. Diagnostic workup, staging systems, treatments, and outcomes are outlined for several subtypes affecting different areas of the GI tract, such as diffuse large B-cell lymphoma and MALT lymphoma in the stomach, and immunoproliferative small intestinal disease. Throughout, key points are illustrated with images and tables.
This document summarizes gastrointestinal (GI) lymphomas. It discusses:
1. GI lymphomas account for 1-4% of all GI malignancies and are most commonly B-cell lymphomas. The major types are gastric and small intestinal lymphomas.
2. Gastric lymphomas are often marginal zone B-cell lymphoma (MALToma) or diffuse large B-cell lymphoma (DLBCL). MALToma has strong associations with Helicobacter pylori infection and can often be treated with H. pylori eradication therapy. DLBCL requires chemotherapy.
3. Small intestinal lymphomas include MALToma, DLBCL, mantle cell lymphoma, and Burk
This document discusses different types of intestinal polyps. It begins by defining a polyp as an abnormal growth projecting from a mucous membrane. The main types discussed are epithelial polyps, which include adenomas, serrated lesions like hyperplastic polyps and sessile serrated adenomas/polyps, and hamartomas. Adenomas are further classified based on histology and risk of malignancy. Serrated lesions have distinct histologic features and molecular profiles. Certain polyp types are associated with hereditary cancer syndromes like familial adenomatous polyposis. Accurate classification and reporting of polyps helps determine cancer risk and appropriate surveillance for patients.
esophageal carcinoma is one of the common gastrointestinal malignancy. Its usually present at advanced stage. Its management requires diagnosis as early as possible and staging followed by proper planning of treatment. Its treatment include endoscopic, surgical, adjuvant chemotherapy and palliative management.
Mr. NBR, age 42, was admitted with symptoms of jaundice, abdominal pain, dark urine, and clay-colored stools. Investigations revealed multiple stones in the common bile duct. He underwent open cholecystectomy with exploration of the common bile duct and intraoperative cholangiography. Multiple impacted stones were found and removed from the common bile duct and intrahepatic ducts. The patient's postoperative recovery was uncomplicated and he was discharged on the 11th postoperative day after drain removal and suture removal.
Soft tissue sarcomas are rare malignant tumors that can arise in any soft tissue of the body. They are characterized by their genetic alterations and histological grade. Diagnosis is made through biopsy and imaging is used to stage the tumor. Treatment typically involves complete surgical resection with negative margins, along with possible adjuvant radiation and chemotherapy depending on tumor grade and size. Prognosis depends on factors like tumor size, grade, depth, and completeness of resection. Recurrence rates remain high, especially for retroperitoneal and visceral soft tissue sarcomas.
1. Small bowel neoplasms are rare, comprising about 1-2% of gastrointestinal tumors. The most common benign tumors are leiomyomas, adenomas, and gastrointestinal stromal tumors (GISTs), while the most common malignant tumor is adenocarcinoma.
2. Risk factors for small bowel tumors include Crohn's disease, familial polyposis syndromes, and Peutz-Jeghers syndrome. Diagnosis is often difficult but can involve imaging like CT, capsule endoscopy, or surgical exploration.
3. Treatment depends on whether the tumor is benign or malignant and its size and location. Resection is often curative for localized benign and malignant tumors, while
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. They arise from interstitial cells of Cajal and can occur anywhere in the GI tract but are most common in the stomach. GISTs demonstrate mutations in genes like KIT or PDGFRA and are classified based on tumor size and mitotic rate to determine prognosis. Histologically, GISTs can be spindle cell, epithelioid, or mixed cell types and are typically positive for CD117, CD34, and DOG1 by immunohistochemistry, helping differentiate them from other soft tissue tumors. Prognosis depends on factors like tumor size, mitotic rate, site,
1. A 60-year-old male presented with yellowish discoloration of the eye, itching all over the body, pale stools, loss of appetite, and weight loss.
2. Obstructive jaundice and periampullary carcinoma were suspected given his age, painless progressive jaundice, pruritis, pale stools, and weight loss.
3. Key clinical features of obstructive jaundice include jaundice, intense pruritis, pale stools, loss of appetite and weight in patients typically aged 50-70 years.
Zollinger-Ellison Syndrome is caused by gastrinomas, rare neuroendocrine tumors that secrete high levels of gastrin and cause ulcers. Dr. Robert Zollinger and Dr. Edwin Ellison discovered this condition in 1955 after finding non-beta islet cell tumors in two patients with extreme acid hypersecretion and benign jejunal ulcers. Gastrinomas are most commonly found in the duodenum or pancreas and are difficult to diagnose due to their rarity and variable symptoms. Complete surgical resection of localized tumors improves prognosis, but prognosis is worse if liver metastases are present. Controversies remain regarding optimal localization techniques and management approaches for gastrinoma patients with multiple tumors or
This document provides information on gastrointestinal stromal tumors (GISTs) including their definition, epidemiology, etiology, molecular pathogenesis, genetic classification, anatomy, pathology, screening, diagnosis, staging, prognostic factors, risk stratification, management of localized, advanced, inoperable, and metastatic disease, treatment with tyrosine kinase inhibitors, response evaluation, and follow up. GISTs are rare mesenchymal tumors of the GI tract that are driven by mutations in KIT or PDGFRA genes. Surgery is the main treatment for localized disease while advanced disease is treated with tyrosine kinase inhibitors.
Gastrointestinal stromal tumors (GISTs) are rare sarcomas that arise from the gastrointestinal tract. Most commonly found in the stomach, they represent 0.2% of gastrointestinal tumors. While often asymptomatic, they can present with bleeding, pain, or obstruction. Diagnosis involves imaging such as endoscopy or CT scan followed by biopsy showing immunohistochemistry positive for CD117 in 95% of cases. Treatment involves surgical resection with clear margins although adjuvant therapy with imatinib is often used for higher risk tumors. Outcomes have improved greatly in the past two decades with 5-year survival rates now over 50% with appropriate treatment.
This document discusses ampullary carcinomas, including their epidemiology, clinical manifestations, diagnosis, staging, treatment, and prognosis. It provides details on: the average age of diagnosis being 60-70 years old; the most common histologic subtype being intestinal (47%); obstructive jaundice being the most common presenting symptom (80%); diagnostic tests including ERCP, CT, and tumor markers; the TNM staging system; pancreaticoduodenectomy being the standard treatment for localized disease; and adjuvant therapy options including chemotherapy and chemoradiotherapy for stage IB or higher cancers.
This Presentation gives summarized overview of Gall Bladder Carcinoma especially the management as per latest National Comprehensive Cancer Network(NCCN) Guidelines version 2.2013
This document describes contact endoscopy (CE), a non-invasive optical technique that uses a magnifying endoscope to provide real-time visualization and examination of the cellular architecture and vascular patterns of mucosal tissues. CE allows in vivo assessment of precancerous and cancerous lesions without biopsy. Several contact endoscope models from Karl Storz are described. The document outlines CE's applications in examining various head and neck tissues and its ability to detect abnormalities. The benefits of CE include its non-invasive nature, ability to examine large areas quickly, and provision of immediate results.
This document discusses recent advances in gastrointestinal diagnostic and therapeutic endoscopy. It describes various endoscopic techniques for diagnosing and treating gastroesophageal reflux disease (GERD), such as the BRAVO capsule, multi-channel intraluminal impedance (MII), and endoscopic therapies including Endocinch, Stretta, Enteryx, and Gate Keeper. New imaging modalities for small and large bowel are also discussed, including capsule endoscopy, magnetic colonoscopy imaging, and CT colonography. Techniques for screening early gastrointestinal malignancies using interface endoscopy technologies like magnification chromoendoscopy, narrow-band imaging, autofluorescence imaging, and optical coherence tomography are also summarized.
This document discusses various anomalies of the biliary tree that can occur during embryonic development, including choledochal cysts, anomalous pancreatobiliary junction, annular pancreas, and biliary atresia. It describes the embryology of the biliary system and pancreas. Common anomalies are discussed such as their presentation, diagnosis using imaging modalities, classification systems, and management approaches including various surgical procedures.
This document discusses various types of colorectal polyps and polyposis syndromes. It begins by defining different types of colorectal polyps based on size, attachment, cellular architecture, and histological appearance. Larger polyps have a higher likelihood of harboring cancer. The main polyposis syndromes discussed are familial adenomatous polyposis (FAP), hereditary non-polyposis colorectal cancer (HNPCC), Peutz-Jeghers syndrome, and juvenile polyposis syndrome. FAP is characterized by hundreds of colonic polyps and a 100% risk of colon cancer. Management involves prophylactic colectomy and surveillance of other organs for extracol
Barrett's esophagus; guidelines & new endoscopic techniquesMoon Splitting
The man has had heartburn for over 20 years and is concerned about his risk of Barrett's esophagus and esophageal cancer after reading an article. The article recommends those with chronic heartburn undergo endoscopy to evaluate for Barrett's esophagus. The document discusses Barrett's esophagus, its risks factors including longstanding GERD, obesity and male gender. Surveillance endoscopy is suggested for patients with Barrett's esophagus to screen for dysplasia or cancer.
Colonic polyposis refers to numerous polyps throughout the GI tract that are often precancerous. The most common type is familial adenomatous polyposis (FAP), an autosomal dominant condition caused by a mutation in the APC gene. People with FAP develop hundreds to thousands of colon polyps by their mid-30s, and colon cancer is inevitable without surgery to remove the colon. They are also at risk of polyps in the stomach and duodenum that can become cancerous. Treatment involves prophylactic colectomy, surveillance of the upper GI tract, and managing extracolonic manifestations such as osteomas and desmoid tumors.
This document discusses primary lymphomas of the gastrointestinal tract. It begins by providing background on lymphomas and noting that the gastrointestinal tract is a common extra-nodal site. The most common subtypes of primary GI lymphomas are then described, including their typical locations and risk factors. Diagnostic workup, staging systems, treatments, and outcomes are outlined for several subtypes affecting different areas of the GI tract, such as diffuse large B-cell lymphoma and MALT lymphoma in the stomach, and immunoproliferative small intestinal disease. Throughout, key points are illustrated with images and tables.
This document summarizes gastrointestinal (GI) lymphomas. It discusses:
1. GI lymphomas account for 1-4% of all GI malignancies and are most commonly B-cell lymphomas. The major types are gastric and small intestinal lymphomas.
2. Gastric lymphomas are often marginal zone B-cell lymphoma (MALToma) or diffuse large B-cell lymphoma (DLBCL). MALToma has strong associations with Helicobacter pylori infection and can often be treated with H. pylori eradication therapy. DLBCL requires chemotherapy.
3. Small intestinal lymphomas include MALToma, DLBCL, mantle cell lymphoma, and Burk
This document discusses different types of intestinal polyps. It begins by defining a polyp as an abnormal growth projecting from a mucous membrane. The main types discussed are epithelial polyps, which include adenomas, serrated lesions like hyperplastic polyps and sessile serrated adenomas/polyps, and hamartomas. Adenomas are further classified based on histology and risk of malignancy. Serrated lesions have distinct histologic features and molecular profiles. Certain polyp types are associated with hereditary cancer syndromes like familial adenomatous polyposis. Accurate classification and reporting of polyps helps determine cancer risk and appropriate surveillance for patients.
esophageal carcinoma is one of the common gastrointestinal malignancy. Its usually present at advanced stage. Its management requires diagnosis as early as possible and staging followed by proper planning of treatment. Its treatment include endoscopic, surgical, adjuvant chemotherapy and palliative management.
Mr. NBR, age 42, was admitted with symptoms of jaundice, abdominal pain, dark urine, and clay-colored stools. Investigations revealed multiple stones in the common bile duct. He underwent open cholecystectomy with exploration of the common bile duct and intraoperative cholangiography. Multiple impacted stones were found and removed from the common bile duct and intrahepatic ducts. The patient's postoperative recovery was uncomplicated and he was discharged on the 11th postoperative day after drain removal and suture removal.
Soft tissue sarcomas are rare malignant tumors that can arise in any soft tissue of the body. They are characterized by their genetic alterations and histological grade. Diagnosis is made through biopsy and imaging is used to stage the tumor. Treatment typically involves complete surgical resection with negative margins, along with possible adjuvant radiation and chemotherapy depending on tumor grade and size. Prognosis depends on factors like tumor size, grade, depth, and completeness of resection. Recurrence rates remain high, especially for retroperitoneal and visceral soft tissue sarcomas.
1. Small bowel neoplasms are rare, comprising about 1-2% of gastrointestinal tumors. The most common benign tumors are leiomyomas, adenomas, and gastrointestinal stromal tumors (GISTs), while the most common malignant tumor is adenocarcinoma.
2. Risk factors for small bowel tumors include Crohn's disease, familial polyposis syndromes, and Peutz-Jeghers syndrome. Diagnosis is often difficult but can involve imaging like CT, capsule endoscopy, or surgical exploration.
3. Treatment depends on whether the tumor is benign or malignant and its size and location. Resection is often curative for localized benign and malignant tumors, while
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. They arise from interstitial cells of Cajal and can occur anywhere in the GI tract but are most common in the stomach. GISTs demonstrate mutations in genes like KIT or PDGFRA and are classified based on tumor size and mitotic rate to determine prognosis. Histologically, GISTs can be spindle cell, epithelioid, or mixed cell types and are typically positive for CD117, CD34, and DOG1 by immunohistochemistry, helping differentiate them from other soft tissue tumors. Prognosis depends on factors like tumor size, mitotic rate, site,
1. A 60-year-old male presented with yellowish discoloration of the eye, itching all over the body, pale stools, loss of appetite, and weight loss.
2. Obstructive jaundice and periampullary carcinoma were suspected given his age, painless progressive jaundice, pruritis, pale stools, and weight loss.
3. Key clinical features of obstructive jaundice include jaundice, intense pruritis, pale stools, loss of appetite and weight in patients typically aged 50-70 years.
Zollinger-Ellison Syndrome is caused by gastrinomas, rare neuroendocrine tumors that secrete high levels of gastrin and cause ulcers. Dr. Robert Zollinger and Dr. Edwin Ellison discovered this condition in 1955 after finding non-beta islet cell tumors in two patients with extreme acid hypersecretion and benign jejunal ulcers. Gastrinomas are most commonly found in the duodenum or pancreas and are difficult to diagnose due to their rarity and variable symptoms. Complete surgical resection of localized tumors improves prognosis, but prognosis is worse if liver metastases are present. Controversies remain regarding optimal localization techniques and management approaches for gastrinoma patients with multiple tumors or
This document provides information on gastrointestinal stromal tumors (GISTs) including their definition, epidemiology, etiology, molecular pathogenesis, genetic classification, anatomy, pathology, screening, diagnosis, staging, prognostic factors, risk stratification, management of localized, advanced, inoperable, and metastatic disease, treatment with tyrosine kinase inhibitors, response evaluation, and follow up. GISTs are rare mesenchymal tumors of the GI tract that are driven by mutations in KIT or PDGFRA genes. Surgery is the main treatment for localized disease while advanced disease is treated with tyrosine kinase inhibitors.
Gastrointestinal stromal tumors (GISTs) are rare sarcomas that arise from the gastrointestinal tract. Most commonly found in the stomach, they represent 0.2% of gastrointestinal tumors. While often asymptomatic, they can present with bleeding, pain, or obstruction. Diagnosis involves imaging such as endoscopy or CT scan followed by biopsy showing immunohistochemistry positive for CD117 in 95% of cases. Treatment involves surgical resection with clear margins although adjuvant therapy with imatinib is often used for higher risk tumors. Outcomes have improved greatly in the past two decades with 5-year survival rates now over 50% with appropriate treatment.
This document discusses ampullary carcinomas, including their epidemiology, clinical manifestations, diagnosis, staging, treatment, and prognosis. It provides details on: the average age of diagnosis being 60-70 years old; the most common histologic subtype being intestinal (47%); obstructive jaundice being the most common presenting symptom (80%); diagnostic tests including ERCP, CT, and tumor markers; the TNM staging system; pancreaticoduodenectomy being the standard treatment for localized disease; and adjuvant therapy options including chemotherapy and chemoradiotherapy for stage IB or higher cancers.
This Presentation gives summarized overview of Gall Bladder Carcinoma especially the management as per latest National Comprehensive Cancer Network(NCCN) Guidelines version 2.2013
This document describes contact endoscopy (CE), a non-invasive optical technique that uses a magnifying endoscope to provide real-time visualization and examination of the cellular architecture and vascular patterns of mucosal tissues. CE allows in vivo assessment of precancerous and cancerous lesions without biopsy. Several contact endoscope models from Karl Storz are described. The document outlines CE's applications in examining various head and neck tissues and its ability to detect abnormalities. The benefits of CE include its non-invasive nature, ability to examine large areas quickly, and provision of immediate results.
This document discusses recent advances in gastrointestinal diagnostic and therapeutic endoscopy. It describes various endoscopic techniques for diagnosing and treating gastroesophageal reflux disease (GERD), such as the BRAVO capsule, multi-channel intraluminal impedance (MII), and endoscopic therapies including Endocinch, Stretta, Enteryx, and Gate Keeper. New imaging modalities for small and large bowel are also discussed, including capsule endoscopy, magnetic colonoscopy imaging, and CT colonography. Techniques for screening early gastrointestinal malignancies using interface endoscopy technologies like magnification chromoendoscopy, narrow-band imaging, autofluorescence imaging, and optical coherence tomography are also summarized.
Esthesioneuroblastoma (ENB) is a rare malignant tumor that arises from the olfactory epithelium in the nasal cavity. Imaging such as CT and MRI are used to determine the extent of the tumor. Histopathological examination shows small round blue cells forming rosettes. Treatment involves surgery such as craniofacial resection along with radiation therapy. For advanced disease, chemotherapy may be given as part of multimodality treatment. With aggressive treatment, 5-year survival rates for ENB exceed 60%.
Narrow-band imaging (NBI) is an endoscopic imaging technique that uses specific blue and green wavelengths of light to enhance visualization of mucosal and vascular patterns. It helps identify subtle abnormalities by highlighting areas with high hemoglobin concentration. In the larynx, NBI has been used to identify recurrent respiratory papillomatosis and screen for malignancies. It provides sharper contrast than white light imaging, allowing for better detection of lesions and guidance of biopsy to suspicious areas. NBI is available for laryngoscopes and gastroscopes and is being explored for its utility in evaluating laryngeal and hypopharyngeal lesions.
This document discusses the anatomy and ultrasound features of thyroid gland diseases. It provides indications for thyroid ultrasound such as enlargement, palpable or non-palpable masses, and abnormal thyroid function tests. Features of benign and malignant solitary nodules and diffuse diseases like Graves' disease and Hashimoto's thyroiditis are described. Benign nodules often appear completely cystic, echogenic or isoechoic with a complete halo and rim calcifications. Malignant nodules frequently have microcalcifications, irregular margins and hypervascularity. Diffuse diseases present with diffuse enlargement and vascular patterns. Ultrasound helps evaluate incidentally detected nodules.
This document discusses various advanced imaging techniques used in gastrointestinal endoscopy to identify early pathology and lesions. It describes technologies like high-definition white light endoscopy, narrow-band imaging, autofluorescence imaging, and confocal laser endomicroscopy. While these techniques have shown promise in clinical trials, most are only widely available in tertiary hospitals. Optical imaging provides improved diagnostic capability and enables real-time "optical biopsies," representing progress toward more effective detection and management of treatable early gastrointestinal diseases.
1) Parotid gland tumors are relatively uncommon, accounting for less than 1% of reported malignancies. Pleomorphic adenoma is the most common parotid gland tumor, comprising 60% of cases.
2) The document outlines the classification, presentation, diagnostic evaluation, surgical and treatment options for parotid gland tumors. It also presents representative cases from the author's experience.
3) Superficial parotidectomy with preservation of the facial nerve is the most common surgical intervention undertaken and was performed in 95% of cases. Post-operative complications included transient or permanent facial nerve weakness.
Juvenile angiofibroma is a rare, benign and highly vascular tumor that develops almost exclusively in adolescent males within the sphenopalatine foramen. It presents with recurrent severe nosebleeds and progressive nasal obstruction. Imaging such as CT and MRI are used to determine the extent of the tumor. While surgery is the primary treatment, preoperative embolization and endoscopic resection are often used for early-stage tumors to reduce bleeding and complications. Advanced tumors may require open approaches like mid-facial degloving. Recurrence rates remain high due to the invasive nature of the tumor.
Presentation1.pptx, radiological imaging of divertiular disease and diverticu...Abdellah Nazeer
This document summarizes the key radiological imaging techniques used to diagnose and monitor diverticular disease and diverticulitis of the colon. It describes the epidemiology and pathophysiology of diverticular disease. Computed tomography is outlined as the gold standard imaging method, able to detect wall thickening, inflammation, abscesses, fistulas, and complications. Ultrasound, barium enema, and magnetic resonance imaging are also discussed. The document presents various images demonstrating diverticulitis findings on the different modalities.
Dept of Oral Medicine & Radiology
Ameloblastoma A case report
Dhananjay Singh
CHIEF COMPLAINT
HISTORY OF PRESENT ILLNESS
dental history
medical history
diagnosis
investigation
final diagnosis
treatment
clinical features
oral medicine
radiology
xray
oral diagnosis
[1] Ocular Surface Squamous Neoplasia (OSSN) refers to a spectrum of dysplastic and malignant squamous lesions of the conjunctiva and cornea.
[2] Diagnosis is usually clinical but can be confirmed with biopsy. For suspected OSSN less than 3 clock hours, excision biopsy with cryotherapy and alcohol epitheliectomy is performed. Larger lesions may require chemoreduction with topical chemotherapy prior to surgery and cryotherapy.
[3] Risk factors include ultraviolet light, HIV, and human papillomavirus. While rare, metastasis can occur to local lymph nodes or distant sites like lungs. Recurrence after treatment ranges from 15-52% depending
This document discusses oral squamous cell carcinoma (OSCC). It covers the epidemiology, risk factors, early detection methods, premalignant lesions, investigations, management including surgery and reconstruction, and treatment including radiation and chemotherapy. OSCC is the 6th most common cancer worldwide and the most common cancer in Indian men. Tobacco and alcohol are major risk factors. Detection methods include toluidine blue staining and tissue autofluorescence. Premalignant lesions include leukoplakia and erythroplakia. Management involves wide local excision and neck dissection, with reconstruction options like flaps and grafts. Radiation and chemotherapy may be used as adjuvant or palliative treatment.
Odontogenic keratocyst (OKC) is the cyst arising from the cell rests of dental lamina. It can occur anywhere in the jaw, but commonly seen in the posterior part of the mandible. Radiographically, most OKCs are unilocular when presented at the periapex and can be mistaken for radicular or lateral periodontal cyst.
This document discusses the use of chromoendoscopy and narrow band imaging (NBI) with magnification for detecting and diagnosing squamous cell carcinomas (SCCs) in the esophagus and pharynx. It outlines various dyes used in chromoendoscopy and describes findings on NBI like brownish areas and irregularities in intra-epithelial papillary capillary loops that indicate early SCCs. Studies show NBI has significantly higher detection and diagnostic accuracy rates than white light imaging for SCCs in both locations. NBI classification systems are presented to diagnose SCC depth.
This document provides information on various vocal fold surgeries and procedures. It begins with definitions and assessments used for vocal fold surgery. It then discusses different surgical techniques like microlaryngoscopy, vocal fold injections, and laryngeal framework surgery. Specific procedures for conditions like nodules, polyps, Reinke's edema, and papillomas are described. The document also covers topics like laser vs other instruments, anesthesia considerations, post-op voice rest, and complications of procedures. Key surgical principles and the advantages of microlaryngoscopy are highlighted. Different materials used for vocal fold injections and medialization thyroplasty are also discussed.
This document provides information on various benign anorectal diseases. It discusses the anatomy of the rectum and anal canal and describes common conditions such as hemorrhoids, anal fissures, anorectal abscesses, anal fistulas, proctitis, pruritis ani, and rectal prolapse. For each condition, it covers definitions, causes, symptoms, examinations, investigations and treatments. The document also provides details on the clinical features, diagnosis and management of various anorectal diseases.
Breast ultrasound uses high-frequency sound waves to map the internal structures of the breast. Though it should not be used alone for screening, ultrasound can detect cancers not seen on mammography when used together with mammography. With new transducers, ultrasound can also detect malignancy associated with clustered microcalcifications seen on mammograms. Ultrasound provides high quality images of the normal and abnormal breast and can help differentiate between cystic and solid lesions.
This case study describes a 32-year-old male patient with a history of upper GI bleeding, anorexia, and weight loss who was found to have Familial Adenomatosis Polyposis (FAP) based on multiple colon polyps seen on colonoscopy and confirmation on CT scan. CT scan also showed multiple mesenteric masses diagnosed as desmoid tumors based on biopsy, confirming a diagnosis of Gardner's Syndrome. The patient underwent proctocolectomy followed by chemotherapy for the desmoid tumors, which were later found to have metastasized on follow up CT scans. Stenting was required to relieve duodenal obstruction caused by a desmoid tumor. The case outlines the key features of FAP
Presentation1.pptx, radiological imaging of salivary glands diseases.Abdellah Nazeer
This document discusses various imaging modalities used to assess salivary gland diseases including plain film radiography, sialography, CT scan, MRI, diagnostic ultrasound, and nuclear scintigraphy. It provides details on the techniques and findings of each modality. The imaging plays an important role in evaluating symptoms, differentiating lesions, and determining extent of disease. Common diseases discussed include sialadenitis, sialolithiasis, mumps, HIV-related lesions, ranula, lipoma, hemangioma, and Sjogren's syndrome.
Current Concept of Management Gastric Carcinomadrmangual1954
This document discusses current concepts in the management of gastric carcinoma. It provides details on the magnitude of the problem, including annual incidence rates worldwide. It describes the changing scenario of gastric cancer, with increasing rates of proximal gastric cancer. The document discusses diagnostic modalities and pre-operative staging, as well as TNM classification. It outlines surgical management objectives and options, including the extent of lymph node dissection and tumor resection status.
This document discusses using video capsule endoscopy (VCE) to diagnose and monitor Crohn's disease and investigate obscure gastrointestinal bleeding. It also mentions using confocal laser endomicroscopy to examine the small bowel. The presentation concludes by thanking the audience.
This document discusses the causes and management of upper gastrointestinal bleeding. It begins by listing common causes such as portal hypertension, peptic ulcer disease, angiomatous malformations, and neoplasms. For portal hypertension, it focuses on variceal bleeding and techniques for controlling acute variceal hemorrhage such as band ligation, sclerotherapy, and cyanoacrylate injection. For peptic ulcer disease, it covers risk assessment using the Forrest classification and Rockall score, medical and endoscopic treatment options, and the role of H. pylori eradication. It also briefly discusses less common causes of upper GI bleeding like Dieulafoy lesions and telangectasia.
This document discusses metabolic endoscopy and intragastric balloons as a treatment option for obesity. It notes that obesity requires a multidisciplinary approach, and that treatment options include pharmaceutical, interventional, and surgical approaches as well as lifestyle modifications involving nutrition education, psychological support, and medical treatment. Specifically, it focuses on intragastric balloons as an interventional endoscopic technique for obesity treatment, how the balloons work, and their removal process.
Early Detection and Management of Oesophageal and Gastric TumoursHossam Ghoneim
Early Detection and Management of Oesophageal and Gastric Tumours
This document outlines techniques for early detection and management of oesophageal and gastric tumours. It discusses various imaging techniques like chromoendoscopy, magnification endoscopy, narrow-band imaging and autofluorescence imaging that can help differentiate lesions. Early detection is important for conditions like Barrett's esophagus and early gastric cancer. Management options discussed include endoscopic mucosal resection and endoscopic submucosal dissection, with ESD providing better en bloc resection rates but being more complex. The document provides an overview of current guidelines and research findings on classifying, detecting and treating premalignant and malignant conditions of the upper GI tract.
This document discusses obesity and various treatment options. It defines BMI ranges for normal weight, overweight, obese, and morbidly obese. Treatment options include surgical procedures like gastric bypass and banding, as well as non-surgical options like weight loss programs, pharmaceutical agents, and intragastric balloons. New treatment developments discussed include the intragastric BIB balloon system, newer pharmaceuticals like Contrave and Liraglutide, endoscopic procedures like Endobarrier, and the laparoscopic MAESTRO V-bloc neuroblocking system. The document emphasizes a team-based approach and lists criteria for success and complications of different treatments.
This document discusses obscure gastrointestinal bleeding (OGIB), which constitutes about 5% of GI bleeding cases and can have significant morbidity and mortality. OGIB is bleeding of unknown origin after an initial negative endoscopic evaluation. It may present as recurrent iron deficiency anemia, fecal occult blood tests, melena, or hematochezia. Evaluation tools include video capsule endoscopy (VCE), push enteroscopy, double balloon enteroscopy, single balloon enteroscopy, intra-operative enteroscopy, and imaging. VCE has a high sensitivity of 89-92% and specificity of 95% for detecting small bowel lesions that may have been missed on previous endoscopies. Common VCE findings in cases of OGIB
A 19-year-old female presented with dysphagia and odynophagia for a few days without weight loss or other symptoms. Examination found normal vital signs and no other abnormalities. Endoscopy initially showed an upper esophageal lesion of unclear etiology. Narrow band imaging revealed the lesion to be inflammatory and ulcerative rather than cancerous. Further history revealed the patient was taking tetracycline with only sips of water while lying down, confirming the diagnosis of pill esophagitis. No local endotherapy was needed at this time unless a benign stricture develops.
This document discusses four clinical cases involving gallstones and bile duct issues.
Case 1 involves a 40-year-old woman with acute gallstone pancreatitis who underwent medical treatment and may require surgery if symptoms recur. Case 2 is a 53-year-old woman with vague upper abdominal symptoms who was managed medically with follow up. Case 3 is a 67-year-old woman with jaundice, weight loss, and elevated tumor marker found to have a hilar mass requiring further investigation and management. Case 4 is a 41-year-old woman with acute gallstone pancreatitis and CBD stones seen on ultrasound who requires further evaluation and treatment.
Celiac disease is a chronic autoimmune disorder caused by an inability to tolerate gluten, which is found in wheat, rye, and barley. It affects around 1% of the global population and is diagnosed through blood tests, genetic testing, and confirmation via small intestine biopsy showing villous atrophy. The only treatment is strict, lifelong adherence to a gluten-free diet. Left untreated, it can lead to malnutrition and various complications.
Closing the Gab between Blue Ocean Strategy and Execution by W.Chan Kim and R...Hossam Ghoneim
The document provides an overview of blue ocean strategy (BOS). It defines BOS as creating a market without competition by innovating in a way that makes existing competitors irrelevant. It discusses how to formulate a BOS through tools like reconstructing market boundaries and focusing on value innovation over competition. It also emphasizes the importance of execution, noting keys like overcoming organizational hurdles, building execution into the strategy, and maintaining sustainability. The document uses the example of Comic Relief, a UK charity, to illustrate how aligning the value, people, and profit propositions can create differentiation and low costs to achieve a successful BOS.
This document presents a case study of a 31-year-old female patient complaining of worsening heartburn impairing her quality of life for the past year. A trial of PPI therapy provided marked improvement in her symptoms. Two months later, her symptoms recurred, and an endoscopy showed a small hiatal hernia with no signs of reflux and positive H. pylori infection. Ambulatory pH monitoring showed pathological acid reflux. She was treated for H. pylori and maintained on PPI therapy, but complained of increased nocturnal heartburn on step-down therapy. The document discusses various treatment approaches and indications for surgery.
NAFLD is a disease caused by obesity and epigenetic factors such as having an obese mother or not being breastfed. The disease begins with excess fat building up in the liver due to obesity which can then progress to inflammation and damage of the liver cells if not addressed. The pathogenesis involves genetic and environmental factors that influence how the body processes and stores fat in the liver.
This document provides an overview of liver disease, including the anatomy and blood flow of the liver, histology, cirrhosis, and complications of liver disease such as portal hypertension, ascites, and hepatocellular carcinoma. It also discusses the evaluation and scoring of liver disease severity, as well as nutrition recommendations for patients with liver disease. Key points covered include maintaining adequate protein intake while limiting salt and, in some cases, fat and carbs depending on the stage of liver disease.
The document discusses the history and use of intragastric balloons for weight loss. It provides details on early balloon models from the 1980s that had problems, as well as criteria developed in 1987 for effective balloons. The BIB system balloon is described as round, smooth, and saline-filled to avoid issues of earlier models. Experience with over 400 patients in Egypt is summarized, finding weight loss of 15-25kg on average with few complications and high success rates. Contraindications and ideal candidates for the procedure are also outlined.
This document provides an overview of the immunology of parasitic diseases. It discusses the immune system and its response to parasitic infections, including the roles of innate immunity, acquired immunity, T helper cells, macrophages, B cells, and antibodies. It also covers immunopathogenesis, immunodiagnosis, and approaches to immunization against parasitic diseases.
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterized by abdominal pain and altered bowel habits without any organic cause. It affects 3-22% of the population worldwide. While the exact cause is unclear, it is believed to involve altered gut motility, hypersensitivity, and psychosocial factors. Diagnosis is made based on symptoms according to the Rome criteria and excludes other conditions. Treatment involves dietary modifications, medications to target predominant symptoms such as fiber for constipation or alosetron for diarrhea, and treatment of accompanying psychiatric conditions like anxiety or depression.
This document provides an overview of inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease. Some key points:
- IBD is a group of chronic inflammatory disorders of the gastrointestinal tract of unknown cause. UC primarily involves the colonic mucosa, while Crohn's can involve all layers of the intestinal wall.
- Treatment involves medications to control inflammation like aminosalicylates, corticosteroids, immunosuppressants, antibiotics, and antispasmodics. Surgery is reserved for complications.
- UC has a 20-25% risk of requiring colectomy. Prognosis is variable but long-term mortality is around 5
This document discusses the liver's functions in detoxification and drug metabolism. It outlines the liver's two main detoxification pathways, phase 1 and phase 2 reactions, which involve oxidation and conjugation reactions to make substances more water soluble and able to be excreted. Certain dermatology drugs can cause hepatotoxicity through intrinsic or idiosyncratic mechanisms. Ketoconazole and tetracycline are highlighted as drugs that have been associated with hepatotoxicity ranging from mild elevations in liver enzymes to rare cases of fulminant hepatitis.
1) Hepatitis C infection rates vary widely across regions in Egypt, ranging from 5.9% in Alexandria to 28.4% in Lower Egypt.
2) Guidelines for diagnosing and treating Hepatitis C infection in Egypt involve testing for HCV antibodies and PCR, conducting clinical exams and liver tests, and considering factors like comorbidities and disease stage to determine treatment approach.
3) Treatment options have expanded in recent years to include all-oral regimens without interferon of varying durations, from one month to a year, improving outcomes and simplifying treatment.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
1. nn Interface EndoscopyInterface Endoscopy
nn Magnification chromoendoscopy.Magnification chromoendoscopy.
nn NBI.NBI.
nn AFI.AFI.
nn OCT.OCT.
nn LaserLaser--scanningscanning confocalconfocal microscopy.microscopy.
nn Raman Spectroscopy.Raman Spectroscopy.
nn Light scattering spectroscopy.Light scattering spectroscopy.
nn BioendoscopyBioendoscopy..
2. MagnificationMagnification
ChromoendoscopyChromoendoscopy
nn Allows fine topographical details to be seen.Allows fine topographical details to be seen.
nn Scopes available from x8 to x170 magnification.Scopes available from x8 to x170 magnification.
nn Lens has to be close to surface of mucosa (interface)Lens has to be close to surface of mucosa (interface)
due to narrow range of focus.due to narrow range of focus.
nn With dye (MB or LI) healthy mucosa isWith dye (MB or LI) healthy mucosa is
homogenously stained, non healthy mucosahomogenously stained, non healthy mucosa
heterogeneous pattern or not stained.heterogeneous pattern or not stained.
nn Allows differentiation ofAllows differentiation of adenomatousadenomatous fromfrom
hyperplastichyperplastic tissue according to mucosal patterntissue according to mucosal pattern
((KudoKudo classification).classification).
3. IntroductionIntroduction
nn Chromoendoscopy developed in Japan in the 1970Chromoendoscopy developed in Japan in the 1970’’s .s .
nn Chromoendoscopy uses chemical compounds asChromoendoscopy uses chemical compounds as
stains or contrast agents to high lightstains or contrast agents to high light subbtesubbte mucosalmucosal
surface changes or Abnormal gastrointestinalsurface changes or Abnormal gastrointestinal
epithelium.epithelium.
(H.(H. HitookaHitooka, Japan, 2000)., Japan, 2000).
nn Endoscopic tattooing is a different technique where aEndoscopic tattooing is a different technique where a
specific sight in the GIT is labeled by an intramuralspecific sight in the GIT is labeled by an intramural
injection of a carbon ink suspension solution forinjection of a carbon ink suspension solution for
future surgical or endoscopesfuture surgical or endoscopes indentificationindentification..
(Acosta MM, et al., 1998).(Acosta MM, et al., 1998).
4. Introduction (contIntroduction (cont’’d)d)
nn PronasePronase (antifoam agent)(antifoam agent) premedicationpremedication, significantly, significantly
shortenesshortenes the time forthe time for chromendoscopychromendoscopy and alsoand also
allows for better visualization.allows for better visualization. ((FujiiFujii T, et al., 1998).T, et al., 1998).
nn There are three basic types (methods) ofThere are three basic types (methods) of
chromoendoscopychromoendoscopy
nn Contrast methodContrast method
nn Staining methodStaining method
nn Reaction methodReaction method
nn Several dyes can be used in chromoendoscopy all ofSeveral dyes can be used in chromoendoscopy all of
which are safe, very poorly absorbed from the GITwhich are safe, very poorly absorbed from the GIT
and do not permanently stain the mucosa.and do not permanently stain the mucosa. (H.(H.
MitookaMitooka, 2000)., 2000).
5. Short Summary on Types ofShort Summary on Types of
ChromoendoscopyChromoendoscopy
Dyes
Blue Others
•Contrast & staining methods
•Indigo Carmine & Meth.blue
•GIT morphology
•Reaction method
•Lugol & Congo red
•GIT secretory functions
6. Narrow Band Imaging (NBI)Narrow Band Imaging (NBI)
nn Based on the fact that light penetration is wave lengthBased on the fact that light penetration is wave length
dependant; the shorter the WL the shallower the penetration.dependant; the shorter the WL the shallower the penetration.
nn NBI system consists of a filter with narrow band passNBI system consists of a filter with narrow band pass--
ranges, increased blue light (WL 437nm) & decreased red lightranges, increased blue light (WL 437nm) & decreased red light
(WL 630 nm) contribution.(WL 630 nm) contribution.
nn Real time endoscopic technique that enhances visibility ofReal time endoscopic technique that enhances visibility of
mucosal surface structures without use dye ( mucosal pattern ).mucosal surface structures without use dye ( mucosal pattern ).
Endoscopy, 2003Endoscopy, 2003
7. nn Integrated system with HRE mode & possibility ofIntegrated system with HRE mode & possibility of
switching between both modes.switching between both modes.
nn Few studies performed in comparison toFew studies performed in comparison to
conventional endoscopy in BE, showing betterconventional endoscopy in BE, showing better
IntestinalIntestinal metaplasiametaplasia & HGD detection with NBI& HGD detection with NBI
system.system.
NBINBI
12. Colorectal Polyps
n Definition:
n The term "polyp" refers to any circumscribed mucosal
growth, either flat, depressed, sessile or pedunculated,
that is visible through an endoscope, a magnifying
glass or a stereo-microscope.
n From the Greek:
n polys: many
n pous: the foot
n Many footed
13. ClassificationClassification
nn NeoplasticNeoplastic (malignant or benign)(malignant or benign)
nn AdenomasAdenomas
nn HistopathologicalHistopathological classificationclassification (Tubular, Villous,(Tubular, Villous,
TubulovillousTubulovillous, Serrated), Serrated)
nn Endoscopic classificationEndoscopic classification ((ExophyticExophytic & Non& Non--exophyticexophytic))
nn Pitt Pattern (Pitt Pattern (KudoKudo’’ss classification)classification)
nn ClinicopathologicalClinicopathological classification (classification ( PolyposisPolyposis syndromes)syndromes)
nn FAP (>100 polyps)FAP (>100 polyps)
nn GardnerGardner (polyps,(polyps, osteomasosteomas,, fibromatosisfibromatosis, keratinous skin cysts), keratinous skin cysts)
nn TurcotsTurcots (I with(I with gliomaglioma, II with, II with medalloblastomamedalloblastoma))
nn Attenuated FAP (< 100 polyps)Attenuated FAP (< 100 polyps)
nn Hereditary flat adenomasHereditary flat adenomas (old age, proximal(old age, proximal ±± gastric Ca, <100 lesions)gastric Ca, <100 lesions)
nn Muir Torre syndromeMuir Torre syndrome (polyps <100 with basal or sq cell carcinoma)(polyps <100 with basal or sq cell carcinoma)
nn Hereditary mixedHereditary mixed polyposispolyposis syndromesyndrome (all + atypical juvenile polyps)(all + atypical juvenile polyps)
14. nn NeoplasticNeoplastic (cont(cont’’d)d)
nn CarcinomaCarcinoma
nn HNPCCHNPCC
nn LymphomatousLymphomatous polyposispolyposis
nn SubmucosalSubmucosal tumourstumours ( GIST )( GIST )
nn CrcinoidCrcinoid
nn LeomyomaLeomyoma
nn LipomaLipoma
nn SchwannomaSchwannoma
15. nn NonNon--NeoplasticNeoplastic (not(not tumuruostumuruos))
nn HyperplasticHyperplastic polyp (regenerative /polyp (regenerative / metaplasticmetaplastic))
nn Solitary polypsSolitary polyps
nn MultipleMultiple hyperplastichyperplastic polyposispolyposis syndromesyndrome
nn HamartomasHamartomas (malformation)(malformation)
nn PeutzPeutz--JegerJeger syndromesyndrome (children + brown pig(children + brown pig circumoralcircumoral, hands & feet), hands & feet)
nn JuvenileJuvenile polyposispolyposis (retention polyp(retention polyp-- glands retain secretions)glands retain secretions)
nn Cowden diseaseCowden disease (polyps + facial skin(polyps + facial skin trichilemmomatrichilemmoma))
nn Inflammatory polyps (exaggeratedInflammatory polyps (exaggerated hyperplastichyperplastic))
nn Inflammatory fibroid polyps (Connective tissue overgrowth)Inflammatory fibroid polyps (Connective tissue overgrowth)
nn CronkiteCronkite--CanadaCanada polyposispolyposis syndromesyndrome (sessile diffuse(sessile diffuse polpypspolpyps,,
Alopecia,Alopecia, hyperpigmentationhyperpigmentation & dystrophic nail changes)& dystrophic nail changes)
nn Lymphoid hyperplasiaLymphoid hyperplasia
nn SchistosomalSchistosomal polypspolyps
16. nn PolypPolyp--like Lesionslike Lesions
nn DALMDALM
nn AntibioticAntibiotic--associated Colitisassociated Colitis
nn Foreign bodiesForeign bodies
nn CondylomaCondyloma acuminatumacuminatum
nn PneumatosisPneumatosis cystoidscystoids intestinalisintestinalis
nn Gas forming bacteriaGas forming bacteria
nn due to mucosal breaks ( e.g. with CD, Drugs,..)due to mucosal breaks ( e.g. with CD, Drugs,..)
nn Fatal in childrenFatal in children
24. AdenomatousAdenomatous polypspolyps
NONNON--ExophyticExophytic
nn Previously termedPreviously termed ““FlatFlat--AdenomasAdenomas””..
nn Important feature is that highImportant feature is that high--gradegrade dysplasiadysplasia, occurs more, occurs more
frequently than infrequently than in exophyticexophytic adenomas of the same size.adenomas of the same size.
nn NonNon--ExophyticExophytic adenomas that extend superficially over relativelyadenomas that extend superficially over relatively
wide area are calledwide area are called LSTLST (Laterally spreading(Laterally spreading tumourstumours)) oror CreepingCreeping
tumourstumours..
nn IIaIIa ++ IIcIIc,, IIcIIc && IIcIIc ++ IaIa are more frequently associated with highare more frequently associated with high
gradegrade dysplasiadysplasia and carcinoma.and carcinoma.
nn However, carcinoma can start de novo (without identifiableHowever, carcinoma can start de novo (without identifiable
adenoma).adenoma).
nn It is subject of study whether cancer originate from very smallIt is subject of study whether cancer originate from very small
HGD adenomas which are rapidly replaced by expandingHGD adenomas which are rapidly replaced by expanding
malignancy, OR are they just simple adenomas.malignancy, OR are they just simple adenomas.
25. n Flat adenoma remnant from incomplete
mucosectomy. Observe the scar at the
periphery.
26. n A large sessile villous adenoma.
n Hardly noticed small depressed adenoma. After
indigo carmine spraying the depressed area is
clearly seen.
27. n Moderate size sessile adenoma. A small white-
colored hyperplastic polyp is seen at the left
side of the polyp.
28. n A small exophytic lesion in
the ascending colon with a
contiguous area showing a
decreased vascular pattern
(upper left). After dye
spraying a non exophytic
well circumscribed lesion
was detected beside the small
polyp. The histology report
confirmed adenoma in the
small non-exophytic polyp
while the exophytic lesion
was diagnosed as metaplastic
(hyperplastic).
29. FamilialFamilial AdenomatousAdenomatous PolyposisPolyposis
(FAP(FAP))
nn DefinitionDefinition
nn An inherited dominant not sexAn inherited dominant not sex--linked syndrome manifested bylinked syndrome manifested by
outgrowth of multiple (up to thousands) colorectal adenomas thatoutgrowth of multiple (up to thousands) colorectal adenomas that ifif
untreated develop into colorectal cancer.untreated develop into colorectal cancer.
nn IncidenceIncidence
nn Rare.Rare.
nn EtiologyEtiology and pathogenesisand pathogenesis
nn Deletion inDeletion in AdenomatousAdenomatous polyposispolyposis Coli (APC) gene on chromosomeColi (APC) gene on chromosome
5.5.
nn Clinical presentationClinical presentation
nn Multiple colorectal adenomas appearing in the second and thirdMultiple colorectal adenomas appearing in the second and third
decades (usually asymptomatic stage).decades (usually asymptomatic stage).
nn Malignant transformation in 100% by age 40, with changes in boweMalignant transformation in 100% by age 40, with changes in bowell
habits, abdominal pain and passage of blood per rectum.habits, abdominal pain and passage of blood per rectum.
30. FamilialFamilial AdenomatousAdenomatous PolyposisPolyposis
(FAP(FAP))
nn Endoscopic findingsEndoscopic findings
nn Depending on the stage of disease, multiple polyps that mayDepending on the stage of disease, multiple polyps that may
cover large areas of the colorectal mucosa.cover large areas of the colorectal mucosa.
nn When more than 100 adenomas are present the conditionWhen more than 100 adenomas are present the condition
may be diagnosed as FAP.may be diagnosed as FAP.
nn Multiple nonMultiple non neoplasticneoplastic fundicfundic gland gastric polyps aregland gastric polyps are
frequent in FAP patients.frequent in FAP patients.
nn Duodenal adenomas (frequently of nonDuodenal adenomas (frequently of non--exophyticexophytic type) withtype) with
predominance for thepredominance for the periampullaryperiampullary region are present in theregion are present in the
majority of patients.majority of patients.
nn TreatmentTreatment
nn ProphylacticProphylactic colectomycolectomy at an early age.at an early age.
nn Periodic endoscopies with multiple biopsies from duodenalPeriodic endoscopies with multiple biopsies from duodenal
adenomas are recommended for cancer surveillance.adenomas are recommended for cancer surveillance.
31. FamilialFamilial AdenomatousAdenomatous PolyposisPolyposis
(FAP(FAP))
nn VariantsVariants
nn Gardner's syndrome:Gardner's syndrome:
nn FAP associated withFAP associated with gastroduodenalgastroduodenal polypspolyps
(inclusive(inclusive periampullaryperiampullary carcinoma) soft tissuecarcinoma) soft tissue
tumorstumors (desmoids,(desmoids, osteomasosteomas,, fibromasfibromas).).
nn Turcot'sTurcot's syndrome:syndrome:
nn FAP associated with brainFAP associated with brain tumorstumors..
nn Attenuated FAP:Attenuated FAP:
nn Late onset with less number of polypsLate onset with less number of polyps
(preferentially right(preferentially right--sided) but with a stillsided) but with a still
significant risk of colon cancer.significant risk of colon cancer.
33. n Small, non exophytic adenomas can also be seen
in FAP patients.
34. Hereditary nonHereditary non--polypoidpolypoid ColorectalColorectal
Cancer (Cancer (HNPCC)..LynchHNPCC)..Lynch syndromesyndrome
nn DefinitionDefinition
nn AnAn autosomalautosomal, dominantly inherited disorder characterized, dominantly inherited disorder characterized
by the development of small number of colorectal adenomasby the development of small number of colorectal adenomas
that frequently progress into colorectal cancer preferentiallythat frequently progress into colorectal cancer preferentially
on the right colon.on the right colon.
nn PseudonymsPseudonyms
nn Also referred to as Lynch syndromes I and II.Also referred to as Lynch syndromes I and II.
nn IncidenceIncidence
nn May account at least for 5% of all colorectal cancers.May account at least for 5% of all colorectal cancers.
nn EtiologyEtiology and pathogenesisand pathogenesis
nn Inherited defect in the DNA mismatch repair system leadingInherited defect in the DNA mismatch repair system leading
toto microsatellitemicrosatellite instability.instability.
35. Hereditary nonHereditary non--polypoidpolypoid ColorectalColorectal
Cancer (HNPCC)Cancer (HNPCC)
nn Clinical presentationClinical presentation
nn Onset of colorectal cancer before the age 50.Onset of colorectal cancer before the age 50.
nn FirstFirst--degree relatives with history of early onset ofdegree relatives with history of early onset of
colorectal cancer (< 50y) and involving at least twocolorectal cancer (< 50y) and involving at least two
generations.generations.
nn ExtraintestinalExtraintestinal cancers in somecancers in some kindredskindreds (Lynch(Lynch
syndrome II), specially endometrium, ovary and breast.syndrome II), specially endometrium, ovary and breast.
Less often gastric, ovarian, pancreatic and transitionalLess often gastric, ovarian, pancreatic and transitional
cell carcinoma of thecell carcinoma of the ureterureter and renal pelvis.and renal pelvis.
nn Endoscopic findingsEndoscopic findings
nn Colorectal cancers with rightColorectal cancers with right--side predominance.side predominance.
nn On early stage of disease, small number of polypsOn early stage of disease, small number of polyps
throughout the colon with predominance of the nonthroughout the colon with predominance of the non--
exophyticexophytic type (flat adenomas) for the right colon.type (flat adenomas) for the right colon.
36. Hereditary nonHereditary non--polypoidpolypoid ColorectalColorectal
Cancer (HNPCC)Cancer (HNPCC)
nn DiagnosisDiagnosis
nn Onset of CRC before the age 50 in a nonOnset of CRC before the age 50 in a non--FAP patient andFAP patient and fulfillmentfulfillment ofof
the Amsterdam criteria that includes the documented diagnosis ofthe Amsterdam criteria that includes the documented diagnosis of
colorectal cancer in:colorectal cancer in:
nn At least one family member before age 50.At least one family member before age 50.
nn Three or more relatives; one case a firstThree or more relatives; one case a first--degree relative of the other two.degree relative of the other two.
nn At least two generations.At least two generations.
nn ProphylaxisProphylaxis
nn Patients with positive genetic tests (Patients with positive genetic tests (germlinegermline testing of blood DNA ortesting of blood DNA or
somatic testing of tissue) undergo prophylactic subtotalsomatic testing of tissue) undergo prophylactic subtotal colectomycolectomy..
nn ColonoscopicColonoscopic surveillance is the most accepted alternative and can besurveillance is the most accepted alternative and can be
started at 20 years of age.started at 20 years of age.
nn For those with negative genetic testFor those with negative genetic test colonoscopiccolonoscopic surveillance is stillsurveillance is still
indicated as a significant number of individuals presenting adenindicated as a significant number of individuals presenting adenomasomas
or cancers demonstrate no genetic mutations.or cancers demonstrate no genetic mutations.
nn PeriodicPeriodic gynecologicgynecologic examination and others (stomach & UT) should beexamination and others (stomach & UT) should be
done if documented history of cancers at those sites in family mdone if documented history of cancers at those sites in family members.embers.
38. n Tiny and very discrete
non-exophytic adenomas
of the colon in a case of
HNPCC.
39. SubmucosalSubmucosal TumorsTumors of the Colonof the Colon
and Rectumand Rectum
nn DefinitionDefinition
nn Defined as nonDefined as non--epithelialepithelial neoplasmsneoplasms originating fromoriginating from
elements beneath the colorectal mucosa (elements beneath the colorectal mucosa (stromastroma).).
nn PseudonymsPseudonyms
nn GastrointestinalGastrointestinal stromalstromal tumorstumors ((GISTGIST).).
nn IncidenceIncidence
nn Less common than adenomas andLess common than adenomas and hyperplastichyperplastic polyps.polyps.
nn Most common typesMost common types
nn LipomaLipoma,, leiomyomaleiomyoma,, SchwannomaSchwannoma ((neurilemmomaneurilemmoma),),
neurofibromaneurofibroma, granular cell, granular cell tumortumor; and their malignant; and their malignant
counterparts.counterparts. CarcinoidCarcinoid..
40. SubmucosalSubmucosal TumorsTumors of the Colonof the Colon
and Rectumand Rectum
nn LocationLocation
nn LipomasLipomas predominate in the right colon.predominate in the right colon.
nn CarcinoidCarcinoid tumorstumors show preference for the rectum.show preference for the rectum.
nn Clinical presentationClinical presentation
nn Small lesions usually asymptomatic.Small lesions usually asymptomatic.
nn Larger lesions may present with localized pain, partial obstructLarger lesions may present with localized pain, partial obstruction,ion,
palpable mass or as acute or chronic lower GI bleeding.palpable mass or as acute or chronic lower GI bleeding.
nn Endoscopic findingsEndoscopic findings
nn BroadBroad--based elevations covered with intact mucosa.based elevations covered with intact mucosa.
nn Bridging folds.Bridging folds.
nn LipomasLipomas, the most common lesions, appear as yellow, the most common lesions, appear as yellow--coloredcolored roundround
sessile lesions with smooth surface that feels soft when touchedsessile lesions with smooth surface that feels soft when touched with awith a
closed biopsy forceps (cushion sign).closed biopsy forceps (cushion sign).
nn CarcinoidsCarcinoids are usually small yelloware usually small yellow--coloredcolored lesions with hardlesions with hard
consistency.consistency.
41. SubmucosalSubmucosal TumorsTumors of the Colonof the Colon
and Rectumand Rectum
nn DiagnosisDiagnosis
nn Endoscopic findings may be characteristic not requiringEndoscopic findings may be characteristic not requiring
histological confirmation, as in the case ofhistological confirmation, as in the case of lipomaslipomas..
nn In otherIn other tumortumor types the histological diagnosis may betypes the histological diagnosis may be
difficult as biopsies usually do not reach thedifficult as biopsies usually do not reach the submucosasubmucosa..
nn Repeated biopsy at a same point may establish theRepeated biopsy at a same point may establish the
mesenchymalmesenchymal origin.origin.
nn Fine needle aspiration is often helpful butFine needle aspiration is often helpful but cytologiccytologic evidenceevidence
of malignancy can be difficult toof malignancy can be difficult to identifiyidentifiy in smears andin smears and
therefore endoscopic ultrasound is indicated for staging oftherefore endoscopic ultrasound is indicated for staging of
big lesions prior to removal.big lesions prior to removal.
nn Treatment.Treatment.
nn AsymptomaticAsymptomatic lipomaslipomas do not require excision.do not require excision.
nn SmallSmall carcinoidscarcinoids can be excised after submucosal depositioncan be excised after submucosal deposition
of saline.of saline.
nn BigBig tumorstumors should be surgically treated.should be surgically treated.
42. LipomaLipoma of the colonof the colon
n Lipoma of the colon with a prickly pear
appearance and positive cushion sign.
43. CarcinoidCarcinoid of Rectumof Rectum
A: Pedunculated polypoid lesion presenting a
mushroom appearance in the rectum
B: A round and shallow erosion
in the center and a marked mucosal bulge at
the edge of polyp
C: A non-structural pit pattern in the center
with elongated
pits at the edge revealed in magnifying
endoscopy.
44. Colorectal Lymphomatous Polyposis
n A distinctive form of colorectal lymphoma, with
multiple and large nodules with central depression
representing pathologic lymphoid follicles.
46. HyperplasticHyperplastic PolypsPolyps
((MetaplasticMetaplastic polyps)polyps)
nn DefinitionDefinition
nn Small sessile nonSmall sessile non--neoplasticneoplastic elevations withelevations with
predominance in the rectum and at histologypredominance in the rectum and at histology
present a serrated appearance.present a serrated appearance.
nn IncidenceIncidence
nn Up to 70% of adults over 40 years .Up to 70% of adults over 40 years .
nn LocationLocation
nn ExophyticExophytic type:type: more common in rectum andmore common in rectum and
sigmoid colon.sigmoid colon.
nn NonNon--exophyticexophytic type:type: preference for the right colon.preference for the right colon.
47. HyperplasticHyperplastic PolypsPolyps
nn EtiologyEtiology and pathogenesisand pathogenesis
nn Unknown.Unknown.
nn Clinical presentationClinical presentation
nn Asymptomatic.Asymptomatic.
nn Endoscopic findingsEndoscopic findings
nn ExophyticExophytic type:type: Small round nodules with aSmall round nodules with a pale surfacepale surface..
nn NonNon--exophyticexophytic type:type: nonnon--protruding areas frequently covered withprotruding areas frequently covered with
mucus or faeces that become well demarcated after dyemucus or faeces that become well demarcated after dye--spraying.spraying.
At high resolution, after dye spraying,At high resolution, after dye spraying, hyperplastichyperplastic polyps show apolyps show a
pit pattern (starpit pattern (star--like) with regularly distributed round crypts.like) with regularly distributed round crypts.
nn Malignant potentialMalignant potential
nn Considered to be very low (<0.05%). Their relation with serratedConsidered to be very low (<0.05%). Their relation with serrated
adenomas is still a matter of study.adenomas is still a matter of study.
nn The natural course of flatThe natural course of flat hyperplastichyperplastic polyps is still unknown.polyps is still unknown.
48. HyperplasticHyperplastic PolypsPolyps
nn Differential diagnosisDifferential diagnosis
nn Serrated adenomas may present a similarSerrated adenomas may present a similar
endoscopic appearance.endoscopic appearance.
nn TreatmentTreatment
nn No treatment is required for small lesions, but evenNo treatment is required for small lesions, but even
those small lesions may be difficult to differentiatethose small lesions may be difficult to differentiate
from small serrated adenomas.from small serrated adenomas.
nn Flat nonFlat non--exophyticexophytic lesions require multiple biopsieslesions require multiple biopsies
or resection by mucosectomy to exclude theor resection by mucosectomy to exclude the
presence of a serrated adenoma.presence of a serrated adenoma.
49. n Typical view of a
hyperplastic polyp of the
rectum seen as a small
round protrusion with a
pale surface.
n Small hyperplastic polyp
of the rectum.
51. n Flat hyperplastic polyp
with abundant mucous
that attach feces. The
lesion becomes almost
invisible after flushing
with water but is clearly
demarcated with indigo
carmine dye.
52. Serrated AdenomasSerrated Adenomas
nn DefinitionDefinition
nn A distinct form of colorectalA distinct form of colorectal neoplasianeoplasia wherewhere adenomatousadenomatous glandsglands
have the serrated epithelial arrangement as inhave the serrated epithelial arrangement as in hyperplastichyperplastic polyps.polyps.
nn LocationLocation
nn More common in rectum and sigmoid colon.More common in rectum and sigmoid colon.
nn EtiologyEtiology and pathogenesisand pathogenesis
nn UnknownUnknown etiologyetiology..
nn It has been suggested that serrated adenomas could be a reflectiIt has been suggested that serrated adenomas could be a reflectionon
of theof the neoplasticneoplastic transformation of a more differentiated cell in thetransformation of a more differentiated cell in the
colonic crypt than the traditional adenomacolonic crypt than the traditional adenoma
nn Clinical presentationClinical presentation
nn Small lesions are asymptomatic. Larger lesions may undergoSmall lesions are asymptomatic. Larger lesions may undergo
malignant transformation.malignant transformation.
nn Endoscopic findingsEndoscopic findings
nn Small serrated adenomas frequently have a similar endoscopicSmall serrated adenomas frequently have a similar endoscopic
appearance as that ofappearance as that of hyperplastichyperplastic polyps.polyps.
54. JuvenileJuvenile PolyposisPolyposis
nn DefinitionDefinition
nn A syndrome characterized by the occurrence of multipleA syndrome characterized by the occurrence of multiple hamartomashamartomas
in the colon and less frequently in stomach and small intestine.in the colon and less frequently in stomach and small intestine.
nn IncidenceIncidence
nn Very rare.Very rare.
nn EtiologyEtiology and pathogenesisand pathogenesis
nn Most probably genetically predetermined. Some cases have a clearMost probably genetically predetermined. Some cases have a clear
autosomalautosomal dominant pattern of inheritance.dominant pattern of inheritance.
nn Clinical presentationClinical presentation
nn Rectal bleeding, growth retardation usually appears in childhoodRectal bleeding, growth retardation usually appears in childhood..
nn Endoscopic findingsEndoscopic findings
nn Multiple polyps in colon & rectum that resembleMultiple polyps in colon & rectum that resemble exophyticexophytic adenomas.adenomas.
nn TreatmentTreatment
nn Due to a low but present risk of malignant transformationDue to a low but present risk of malignant transformation
prophylacticprophylactic colectomycolectomy has been proposed for numerous polyps.has been proposed for numerous polyps.
nn ColectomyColectomy may also be necessary to control bleeding.may also be necessary to control bleeding.
nn If few polyps are present, endoscopic polypectomy with followIf few polyps are present, endoscopic polypectomy with follow--up.up.
55. n Different views of a pedunculated polyp with
small craters. The histological outcome was
compatible with a hamartoma.
63. DysplasiaDysplasia Associated Lesion or MassAssociated Lesion or Mass
(DALM)(DALM)
nn DefinitionDefinition
nn A colorectal lesion detected at endoscopy in mucosa affected byA colorectal lesion detected at endoscopy in mucosa affected by
inflammatory bowel disease that at histology revealsinflammatory bowel disease that at histology reveals premalignantpremalignant
((dysplasticdysplastic) changes.) changes.
nn LocationLocation
nn Colon and rectum.Colon and rectum.
nn EtiologyEtiology and pathogenesisand pathogenesis
nn The risk of cancer increases with duration and extension of diseThe risk of cancer increases with duration and extension of disease.ase.
nn These lesions are highly associated withThese lesions are highly associated with adenocarcinomaadenocarcinoma..
nn Clinical presentationClinical presentation
nn The majority of lesions are asymptomatic and are only detected dThe majority of lesions are asymptomatic and are only detected duringuring
colonoscopiccolonoscopic surveillance.surveillance.
nn Endoscopic findingsEndoscopic findings
nn PolypPolyp--like lesions, plaques or flat areas with villous changes.like lesions, plaques or flat areas with villous changes.
64. DysplasiaDysplasia Associated Lesion or MassAssociated Lesion or Mass
(DALM)(DALM)
nn DiagnosisDiagnosis
nn Multiple biopsies should be taken from suspicious areas andMultiple biopsies should be taken from suspicious areas and
from the adjacent mucosa in separated bottles.from the adjacent mucosa in separated bottles.
nn For some investigators DALM only exists when theFor some investigators DALM only exists when the
neoplasticneoplastic lesion is accompanied bylesion is accompanied by dysplasiadysplasia in thein the
surrounding mucosa.surrounding mucosa.
nn NeoplasticNeoplastic noninvasivenoninvasive lesions withoutlesions without dysplasiadysplasia in thein the
surrounding mucosa are simply diagnosed as adenomas.surrounding mucosa are simply diagnosed as adenomas.
nn TreatmentTreatment
nn Small and isolated lesions withoutSmall and isolated lesions without dysplasiadysplasia in adjacent orin adjacent or
distal segments of flat mucosa can bedistal segments of flat mucosa can be resectedresected
endoscopicallyendoscopically..
nn For widespread lesions occupying large areas or lesionsFor widespread lesions occupying large areas or lesions
associated withassociated with dysplasiadysplasia in adjacent or distal segmentsin adjacent or distal segments
proctocolectomyproctocolectomy is recommended.is recommended.
65. Condyloma Acuminatum
n Early condyloma
acuminatum of the
anal canal seen as
multiple small white
convex projections
that become
confluent.
66. Melanosis coli
n A brown mucosal
pigmentation resulting
from chronic laxative
use.
n Multiple lymph follicles,
appearing as white
round spots, contrast
with the surrounding
brown-colored mucosa.
67. n Mild form of antibiotic-associated colitis with
multiple small raised plaques.
70. n Colorectal adenomas are classically defined as
intramucosal neoplasias not extending into the
muscularis mucosae.
n Colorectal cancer is classically defined as a neoplasia
extending beyond the muscularis mucosae.
71. Adenoma-carcinoma Sequence
n Time perspective.
n The development of a colonic adenoma from normal
epithelium can take about 10-20 years.
n The development of carcinoma from an adenoma may
take as little as two years and as much as thirty years.
74. Determinants of Malignant
Transformation
n Polyp size.
n The bigger the adenoma, the higher the risk of malignancy.
n Exophytic adenomas under 1 cm very seldom harbor cancer
while lesions over 2 cm in up to 50% of cases harbor cancer.
n The amount of villous component.
n The malignancy rate for tubular adenomas is low while in
villous adenomas up to 30-40%.
n Small adenomas are usually of tubular type. As they grow so
increases the villous component.
n The grading of dysplasia.
n The malignant potential of adenomas increases with increasing
degrees of dysplasia. The grade of dysplasia is directly related to
size and villous component.
75. nn PolyposisPolyposis syndromessyndromes
nn are at an increased risk of malignant transformation, e.g. 100%are at an increased risk of malignant transformation, e.g. 100%
in FAP.in FAP.
nn Round figure of malignant transformation in all adenomasRound figure of malignant transformation in all adenomas
isis ±± 5 %.5 %.
nn NonNon-- neoplasticneoplastic polypspolyps
nn E.g.E.g. hyperplastichyperplastic (especially if solitary), Juvenile,(especially if solitary), Juvenile, PeutzPeutz--jegerjeger
have a negligible rate of malignant transformationhave a negligible rate of malignant transformation..
78. Colon preparationColon preparation
nn FermantableFermantable sugars (assugars (as mannitolmannitol) are osmotic) are osmotic
good cleansing agents but carry the potential riskgood cleansing agents but carry the potential risk
ofof ““intracolonicintracolonic explosionexplosion””..
nn COCO22 insufflationinsufflation was previously used to preventwas previously used to prevent
sparkspark--induced explosions. Also, it was absorbedinduced explosions. Also, it was absorbed
much quicker from the colon thus preventing postmuch quicker from the colon thus preventing post
colonoscopy cramps & distension.colonoscopy cramps & distension.
79. Cold Biopsy Polypectomy
n For small sessile polyps < 5 mm.
n Bleeding is insignificant & will stop spontaneously
(usually small capillary bleeding).
80. Hot Biopsy Polypectomy
n A small polyp is grasped and
pulled with the biopsy forceps
and thereafter electrocautery is
applied. The base then becomes
white.
n Suitable for polyps <5mm.
81. Cold Snare Polypectomy
n For small sessile polyps < 6-7mm.
n Bleeding is insignificant & will stop spontaneously
(usually small capillary bleeding).
83. Piecemeal Polypectomy
n The base of a large sessile
adenoma is infiltrated with
1:10000 adrenaline in
hypertonic saline and snare
polypectomy is performed
thereafter.
n The remaining adenomatous
area is subsequently excised
with the snare.
n The ulceration was closed by
placing four metal clips.
87. Tips for difficult polypectomyTips for difficult polypectomy
nn Polyp positionPolyp position
nn It is considerably easier to snare polyps in the "six o'clock poIt is considerably easier to snare polyps in the "six o'clock position"sition"
because the snare enters the field roughly at this orientation.because the snare enters the field roughly at this orientation. Since theSince the
optical element is located above the working channel of the endooptical element is located above the working channel of the endoscope,scope,
attempting to capture polyps at other orientations may result inattempting to capture polyps at other orientations may result in losinglosing
the visual field against a fold prior to capture of the polyp.the visual field against a fold prior to capture of the polyp.
nn It is easier to remove a polyp duringIt is easier to remove a polyp during colonoscoepecolonoscoepe withdrawal as thewithdrawal as the
loops are removed, because both torque and tip deflection are moloops are removed, because both torque and tip deflection are morere
responsive when theresponsive when the colonoscopecolonoscope is straightened.is straightened.
nn Placement of the snare is often facilitated by advancing proximaPlacement of the snare is often facilitated by advancing proximal to thel to the
lesion, deploying the snare, and dragging it over the polyp.lesion, deploying the snare, and dragging it over the polyp.
nn Changing patient's position is helpful for polyps that become suChanging patient's position is helpful for polyps that become submergedbmerged
in a pool of fluid, or long stalkin a pool of fluid, or long stalk--polyps can change direction.polyps can change direction.
88. nn Access ProblemsAccess Problems
nn Areas where access problems occur commonly are onAreas where access problems occur commonly are on
the medial wall of the cecum, just proximal to thethe medial wall of the cecum, just proximal to the
ileocecalileocecal valve, and on the proximal sides of folds,valve, and on the proximal sides of folds,
flexures, and turns. Large sessile polyps located on theflexures, and turns. Large sessile polyps located on the
proximal side of sharp sigmoid bends can beproximal side of sharp sigmoid bends can be
problematic.problematic.
nn The easiest solution is to remove the polyp inThe easiest solution is to remove the polyp in
retroflexionretroflexion, using an upper GI endoscope (in lt. colon), using an upper GI endoscope (in lt. colon)
oror paediatricpaediatric colonoscopecolonoscope (in rt. Colon).(in rt. Colon).
89. nn Flat PolypsFlat Polyps
nn Although large flat polyps can be fulgurated with a bipolarAlthough large flat polyps can be fulgurated with a bipolar
probe, laser, or APC, many of these lesions can be removedprobe, laser, or APC, many of these lesions can be removed
with conventional snares.with conventional snares.
nn One technique is to position the snare around the lesion andOne technique is to position the snare around the lesion and
aspirate air from the colon. This will collapse the distendedaspirate air from the colon. This will collapse the distended
colon, and the polyp often moves into the snare, then graspcolon, and the polyp often moves into the snare, then grasp
&& resectresect..
nn Alternatively, the polyp can be lifted with submucosalAlternatively, the polyp can be lifted with submucosal
injection of fluid. However, care must be taken to avoidinjection of fluid. However, care must be taken to avoid
excessive fluid injection; it is not harmful, but it can flattenexcessive fluid injection; it is not harmful, but it can flatten
the polyp even further, making it difficult to capture with athe polyp even further, making it difficult to capture with a
conventional snare loop.conventional snare loop.
90. nn SnaresSnares
nn A standard polypectomy snare (25A standard polypectomy snare (25--30 mm in diameter or 3 x30 mm in diameter or 3 x
6 cm) may be difficult to use in locations where there is6 cm) may be difficult to use in locations where there is
insufficient working room to fully open the snare. A miniinsufficient working room to fully open the snare. A mini--
snare (12.5snare (12.5--20 mm diameter or 1.5 x 3 cm) can help, which20 mm diameter or 1.5 x 3 cm) can help, which
will usually open fully, even in restricted areas.will usually open fully, even in restricted areas.
nn Tips to fully open a snare:Tips to fully open a snare:
nn Impact the tip of the snare on the opposite wall to facilitate lImpact the tip of the snare on the opposite wall to facilitate lateralateral
separation of the wires.separation of the wires.
nn A needleA needle--tip snare can be used to impact just above (proximal to) thetip snare can be used to impact just above (proximal to) the
polyp, which serves to anchor the snare, and subsequent deploymepolyp, which serves to anchor the snare, and subsequent deploymentnt
of the snare will force the loop to open.of the snare will force the loop to open.
91. nn Submucosal Injection PolypectomySubmucosal Injection Polypectomy
nn Facilitates safer and easier removal of sessile polyps. fluidFacilitates safer and easier removal of sessile polyps. fluid
lifts the polyp and increases the distance between the base oflifts the polyp and increases the distance between the base of
the polyp and thethe polyp and the muscularismuscularis propriapropria and serosa.and serosa.
nn Most commonly used fluid is normal saline with or withoutMost commonly used fluid is normal saline with or without
epinephrine. This fluid will be reabsorbed; thus, other fluidsepinephrine. This fluid will be reabsorbed; thus, other fluids
have been used in an attempt to prolong the effect, includinghave been used in an attempt to prolong the effect, including
10% glycerol/5% fructose, 50% dextrose, sodium10% glycerol/5% fructose, 50% dextrose, sodium
hyaluronatehyaluronate, and, and hydroxypropylhydroxypropyl methylcellulose.methylcellulose. MB may beMB may be
added to show even distribution of cushion.added to show even distribution of cushion.
nn Fluid is injected using a standardFluid is injected using a standard sclerotherapysclerotherapy needleneedle
placed into theplaced into the submucosasubmucosa at the edge of a polyp, or if theat the edge of a polyp, or if the
polyp is large and flat, multiple injections may be givenpolyp is large and flat, multiple injections may be given
around the periphery. The desired elevation may require 3around the periphery. The desired elevation may require 3--44
mLmL of saline, although larger volumes can be injected safely.of saline, although larger volumes can be injected safely.
92. nn Inject the proximal (far) aspect of the polyp first. If the distInject the proximal (far) aspect of the polyp first. If the distal aspectal aspect
(closest to the endoscope, and the most tempting) is injected fi(closest to the endoscope, and the most tempting) is injected first, therst, the
polyp can be tilted away from thepolyp can be tilted away from the colonoscopecolonoscope, making resection more, making resection more
difficult. If a bleb does not immediately form, slowly withdrawdifficult. If a bleb does not immediately form, slowly withdraw and liftand lift
the needle slightly while injecting until bleb formation is obsethe needle slightly while injecting until bleb formation is observed. It isrved. It is
often helpful to inject at the lateral margin of the cushion prooften helpful to inject at the lateral margin of the cushion produced byduced by
the previous injection (which has already separated the mucosalthe previous injection (which has already separated the mucosal layerlayer
from thefrom the muscularismuscularis propriapropria).).
93. nn Rotate to 6 oRotate to 6 o’’clock positionclock position ±±
change patient position.change patient position.
nn InjectInject submucosalysubmucosaly ((coecalcoecal toto
anal).anal).
nn Snare & cut.Snare & cut.
94. nn If a bleb does not form, the needle may have penetrated theIf a bleb does not form, the needle may have penetrated the
colon wall, or the failure to lift may indicate the presence ofcolon wall, or the failure to lift may indicate the presence of
invasive cancer that is tethering the polyp to the underlyinginvasive cancer that is tethering the polyp to the underlying
muscularismuscularis propriapropria; or previous biopsying. This is called the; or previous biopsying. This is called the
""nonliftingnonlifting signsign”” oror ““desmoplasticdesmoplastic reactionreaction””..
Flat-depressed early colon cancer
about 10mm in diameter. The
lesion had a borderline size
between an indication and no
indication of EMR. Possibility of
desmoplastic reaction (non-
lifting).
95. nn EMR basic factsEMR basic facts
n Flat lesions up to 20 mm in diameter can relatively easily be
removed by EMR. Larger lesions can be removed piecemeal
but the risk of haemorrhage and perforation increases.
n Before resection the margins of the colonic lesion is determined
by dye spraying.
n Before resection the margins of the colonic lesion is determined
by dye spraying.
n “Grasp and pull" technique is not commonly used for colonic
EMR.
n "Cup and Suction cap" technique has proved less successful for
colonic EMR, because the colonoscope has to be withdrawn
from where the lesion was found for the cap to be fitted, also
risk of perforation was found higher.
96. nn APC after EMRAPC after EMR
nn The goal should be toThe goal should be to resectresect all of the polyp on the first attempt,all of the polyp on the first attempt,
regardless of size, and to ablate any residual flat disease thatregardless of size, and to ablate any residual flat disease that cannot becannot be
resectedresected..
nn NoNo RCTRCT’’ss have compared ablation tools but most experts currentlyhave compared ablation tools but most experts currently
favor the argon plasma coagulator.favor the argon plasma coagulator.
nn Power settings should be 40 watts in thePower settings should be 40 watts in the coecumcoecum, up to 45 watts in the, up to 45 watts in the
right and transverse colon, and can increase progressively in thright and transverse colon, and can increase progressively in the distale distal
colon, and as much as 60 to 65 watts in the distal rectum.colon, and as much as 60 to 65 watts in the distal rectum.
nn Treatment of residual polyp tissue at the base and rim of theTreatment of residual polyp tissue at the base and rim of the
polypectomy site with APC at the time of initialpolypectomy site with APC at the time of initial
polypectomy may decrease recurrence rate.polypectomy may decrease recurrence rate.
97.
98. nn FollowFollow--upup
nn Current guidelines recommend that the polypectomy site ofCurrent guidelines recommend that the polypectomy site of
sessile polyps > 2 cm should be reevaluated in 3sessile polyps > 2 cm should be reevaluated in 3--6 months,6 months,
given the tendency for recurrence.given the tendency for recurrence.
nn LargeLarge pedunculatedpedunculated polyps with highpolyps with high--gradegrade dysplasiadysplasia,,
provided theprovided the endoscopistendoscopist is sure there has been completeis sure there has been complete
resection, can undergo their first followresection, can undergo their first follow--up in three years.up in three years.
nn Unless the lesion is in the cecum or rectum, repeatUnless the lesion is in the cecum or rectum, repeat
localization may be problematic, in which case the colon canlocalization may be problematic, in which case the colon can
bebe endoscopicallyendoscopically tattooed.tattooed.
99. Patients on aspirin or antiplatletes?Patients on aspirin or antiplatletes?
nn Patients taking aspirin for primary prophylaxisPatients taking aspirin for primary prophylaxis
(self(self--prescribed), stop aspirin 7prescribed), stop aspirin 7--10 days before the procedure and10 days before the procedure and
keep off aspirin for up to two weeks after the procedure ifkeep off aspirin for up to two weeks after the procedure if
electrocauteryelectrocautery used.used.
nn If patients are on aspirin with strong indications for preventioIf patients are on aspirin with strong indications for prevention ofn of
cardiovascular orcardiovascular or neurologicneurologic events, do not discontinue the aspirin.events, do not discontinue the aspirin.
nn Absolute risk of bleeding from polypectomy burns, in patients onAbsolute risk of bleeding from polypectomy burns, in patients on
aspirin only, is very low.aspirin only, is very low.
nn Patients taking both aspirin andPatients taking both aspirin and PlavixPlavix have a highhave a high rskrsk of bleeding.of bleeding.
DiscontinueDiscontinue plavixplavix for 5 days before procedure.for 5 days before procedure.
100. nn For patients onFor patients on WarfarinWarfarin
nn Low risk forLow risk for thromboembolismthromboembolism ((atrialatrial fibrillation without leftfibrillation without left atrialatrial dilation, DVT afterdilation, DVT after
six months of therapy),six months of therapy), acceptable to discontinueacceptable to discontinue warfarinwarfarin 3 to 5 days prior to3 to 5 days prior to
colonoscopy and to resume it following the colonoscopy or aftercolonoscopy and to resume it following the colonoscopy or after some delay ifsome delay if
there appears to be a substantial risk of bleeding.there appears to be a substantial risk of bleeding.
nn High riskHigh risk (e.g.(e.g. atrialatrial fibrillation with MV disease and leftfibrillation with MV disease and left atrialatrial dilation, prostheticdilation, prosthetic mitralmitral
valves),valves), acceptable to discontinueacceptable to discontinue warfarinwarfarin and continueand continue LovenoxLovenox as anas an
outpatient, giving the last dose 24 hours prior to the procedureoutpatient, giving the last dose 24 hours prior to the procedure. Both. Both LovenoxLovenox
andand warfarinwarfarin can then be restarted on the evening of the procedure.can then be restarted on the evening of the procedure.
nn LovenoxLovenox is expensive, alternatively, discontinuation ofis expensive, alternatively, discontinuation of warfarinwarfarin, followed by, followed by
hospitalization and intravenoushospitalization and intravenous heparinizationheparinization after the INR drops. In this case,after the INR drops. In this case,
IV heparin is discontinued 4 hours prior to the colonoscopy andIV heparin is discontinued 4 hours prior to the colonoscopy and restarted 4 to 6restarted 4 to 6
hours afterwards.hours afterwards.
nn Whenever patients are to be reWhenever patients are to be re--anticoagulatedanticoagulated, consideration should be given to, consideration should be given to
clipping the polypectomy site.clipping the polypectomy site.
ASGE Guidelines, 2004ASGE Guidelines, 2004
101. Should everyShould every endoscopistendoscopist attempt toattempt to
removeremove everyevery polyp?polyp?
nn This is probably the wrong message to send. Large polypsThis is probably the wrong message to send. Large polyps
are in fact associated with a higher rate of complications.are in fact associated with a higher rate of complications.
Some polyps will require surgical removal, but the bestSome polyps will require surgical removal, but the best
gauge of whether a givengauge of whether a given endoscopistendoscopist should attemptshould attempt
removal is the degree of experience and level of comfort ofremoval is the degree of experience and level of comfort of
thatthat endoscopistendoscopist..
nn However, one should not assume that because one's ownHowever, one should not assume that because one's own
level of comfort is exceeded, that this necessarily mandateslevel of comfort is exceeded, that this necessarily mandates
surgery; in such cases, thesurgery; in such cases, the endoscopistendoscopist should be willing toshould be willing to
consult with a more experienced colleague or considerconsult with a more experienced colleague or consider
referring the patient to another center.referring the patient to another center.
102. Which Polyps Should Be Treated InitiallyWhich Polyps Should Be Treated Initially
With Surgical Resection?With Surgical Resection?
nn Generally accepted criteria for large sessile polypsGenerally accepted criteria for large sessile polyps
that should be referred for surgical removalthat should be referred for surgical removal
nn (1) polyps that laterally encompass more than one(1) polyps that laterally encompass more than one
third of the bowel circumference;third of the bowel circumference;
nn (2) those that extend longitudinally over 2(2) those that extend longitudinally over 2
successivesuccessive haustralhaustral folds;folds;
nn (3) lesions that grossly appear to be malignant ((3) lesions that grossly appear to be malignant (egeg,,
irregular, friable, firm/hard, ulcerated, bleeding);irregular, friable, firm/hard, ulcerated, bleeding);
nn (4) polyps that extend into the appendix, a(4) polyps that extend into the appendix, a
diverticulum, or thediverticulum, or the ileocecalileocecal valve, or otherwisevalve, or otherwise
wrap around a sharp fold.wrap around a sharp fold.
103. Complications of polypectomyComplications of polypectomy
nn Immediate bleedingImmediate bleeding
nn APCAPC
nn Metal clipMetal clip
nn Delayed bleedingDelayed bleeding
nn Few hrs to 12 daysFew hrs to 12 days
nn Occurs in about 2% of casesOccurs in about 2% of cases
nn Emergency colonoscopy neededEmergency colonoscopy needed
if ongoing bleeding. Slowif ongoing bleeding. Slow
tapering bleeding will stoptapering bleeding will stop
spontaneously.spontaneously.
104. nn PerforationPerforation
nn 0.040.04--2.1%2.1%
nn Manifests within few hoursManifests within few hours
nn Clinical presentation is a must (pain), if intra orClinical presentation is a must (pain), if intra or
retroperitoneal air is present, treatretroperitoneal air is present, treat
nn NPO, Antibiotics, and observationNPO, Antibiotics, and observation
nn No clinical presentation but air in imaging =No clinical presentation but air in imaging = ““benignbenign
pneumoperitoneumpneumoperitoneum””, occurs in 1% of colonoscopies, occurs in 1% of colonoscopies
(without intervention). Self(without intervention). Self--limiting.limiting.
nn Large evident perforation (seeingLarge evident perforation (seeing serosalserosal surface of othersurface of other
organs) warrants immediate surgical exploration.organs) warrants immediate surgical exploration.
105. nn Post polypectomy syndromePost polypectomy syndrome
nn TransmuralTransmural burn causing irritation of serosa with aburn causing irritation of serosa with a
localized inflammatory response.localized inflammatory response.
nn Localized pain, tenderness, guarding & rigidity in the areaLocalized pain, tenderness, guarding & rigidity in the area
overlying the polypectomy site;overlying the polypectomy site; ±± fever, tachycardia orfever, tachycardia or
leukocytosis.leukocytosis.
nn Occurs 6hrs to 5 days after 1 % ofOccurs 6hrs to 5 days after 1 % of polypectomiespolypectomies..
nn Usually selfUsually self--limiting in about 2limiting in about 2--5 days; otherwise antibiotics,5 days; otherwise antibiotics,
IV fluids & observation will be enough.IV fluids & observation will be enough.
nn D.D. perforation. Radiographic air present with perforation,D.D. perforation. Radiographic air present with perforation,
absent withabsent with postpolypectomypostpolypectomy syndrome.syndrome.
106. Take home messageTake home message
nn Careful patient evaluation & clinical examination.Careful patient evaluation & clinical examination.
nn Meticulous colonoscopy for minute or flat lesionsMeticulous colonoscopy for minute or flat lesions
nn Tip: watch for abrupt discontinuity of vascular pattern & considTip: watch for abrupt discontinuity of vascular pattern & considerer chromoscopychromoscopy..
nn Perform upper GI endoscopy when SuspiciousPerform upper GI endoscopy when Suspicious
nn E.g. in FAP & FAP variantsE.g. in FAP & FAP variants
nn Which polyps become malignant?Which polyps become malignant?
nn Biopsy & follow report.Biopsy & follow report.
nn KudoKudo’’ss classification.classification.
nn GISTsGISTs can becan be biopsiedbiopsied but do NOT attempt polypectomy.but do NOT attempt polypectomy.
nn Cushion sign ofCushion sign of lipomalipoma (yellow & soft)(yellow & soft)
nn Hard consistency ofHard consistency of CarcinoidCarcinoid (yellow & hard)(yellow & hard)
nn DALM can be removedDALM can be removed endoscopicallyendoscopically if adjacent mucosa is free ofif adjacent mucosa is free of dysplasiadysplasia..
107. nn PolypectomyPolypectomy
nn Position of polypPosition of polyp
nn Position of patientPosition of patient
nn Size of snareSize of snare
nn Submucosal injectionSubmucosal injection
nn APC & metal clips prophylaxis & for complicationsAPC & metal clips prophylaxis & for complications
nn AnticoagulatedAnticoagulated patientspatients
nn Follow up after polypectomyFollow up after polypectomy
nn When to send for surgeryWhen to send for surgery
nn 1/3 of bowel circumference1/3 of bowel circumference
nn 2 successive2 successive haustralhaustral foldsfolds
nn Grossly malignant lesionsGrossly malignant lesions
nn Polyp in diverticulum,Polyp in diverticulum, ileocoecalileocoecal valve, etc.valve, etc.